Not exact matches
Phase I funding — which allows up to $ 250,000 for an academic idea, such as decoding the genetic sequence of a protein or studying
targeted drug delivery
by using magnetic
nanoparticles — is available from federal funding and foundations.
The exterior of the
nanoparticle is coated with nucleic acids that act as
targeting agents, drawing the delivery system to the retina and facilitating uptake
by RPE cells.
Researchers at Penn State have combined the two approaches
by taking biodegradable polymer
nanoparticles encapsulated with cancer - fighting drugs and incorporating them into immune cells to create a smart,
targeted system to attack cancers of specific types.
Now, in a new study using laboratory - grown cells and mice, Johns Hopkins scientists report that a method they used to track metabolic pathways heavily favored
by cancer cells provides scientific evidence for combining anti-cancer drugs, including one in a
nanoparticle format developed at Johns Hopkins, that specifically
target those pathways.
A technique using anesthesia - containing
nanoparticles — drawn to the
targeted area of the body
by magnets — could one day provide a useful alternative to nerve block for local anesthesia in patients, suggests an experimental study in the April issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
To validate their findings, the scientists injected the novel
nanoparticles into pancreatic tumor - bearing mice and observed that
by balancing these two
targets — bringing them to a normal level
by increasing their expression or blocking the gene responsible for their expression — they significantly prolonged the survival of the mice.
For that, they quantified how 85
nanoparticles delivered DNA barcodes to eight cell populations in the spleen, and found that cell types derived from myeloid progenitors tended to be
targeted by similar
nanoparticles.
The
targeted particles with the passports shrank tumors
by 25 % in a single day, while
nanoparticles with the antibodies but without the peptide passports had no effect on the tumor size.
«While
nanoparticle shape has been shown to impact cellular uptake, the latest study shows that specific tissues can be
targeted by controlling the shape of
nanoparticles.
New technique detects
target DNA (here, anthrax)
by using it to link fixed strands with «probe» strands attached to current - carrying gold
nanoparticles.
By synthesizing a
nanoparticle that releases its siRNA cargo only after it enters
targeted cells, Dr. Tariq M. Rana and colleagues showed in mice that they could deliver drugs that silenced the genes they wanted.
A new study shows that a 70 - year - old malaria drug can block immune cells in the liver so
nanoparticles can arrive at their intended tumor site, overcoming a significant hurdle of
targeted drug delivery, according to a team of researchers led
by Houston Methodist.
Nanoparticles capable of delivering drugs to specifically
targeted cancer cells have been created
by a group of researchers from China.
A team of researchers led
by Caltech scientists has shown that
nanoparticles can function to
target tumors while avoiding adjacent healthy tissue in human cancer patients.
The study, «Photosensitivity of Neurons Enabled
by Cell -
Targeted Gold
Nanoparticles,» was supported
by the National Institutes of Health, Beckman Initiative for Macular Research and Research to Prevent Blindness.
Prevention of vascular inflammation
by nanoparticle targeting of adherent neutrophils.
Research Paper Placenta - specific drug delivery
by trophoblast -
targeted nanoparticles in mice Baozhen Zhang, Lunbo Tan, Yan Yu, Baobei Wang, Zhilong Chen, Jinyu Han, Mengxia Li, Jie Chen, Tianxia Xiao, Balamurali K Ambati, Lintao Cai, Qing Yang, Nihar R Nayak, Jian Zhang, Xiujun Fan Theranostics 2018; 8 (10): 2765 - 2781.
The study, conducted
by researchers from Colombia University Medical Center (CUMC), Brigham and Women's Hospital (BWH) and Harvard Medical School (HMS), showed for the first time that it is possible to treat inflammation and repair plaques via highly
targeted nanoparticles.
Farokhzad and colleagues have considerable expertise with bench - to - bedside translation of nanotechnologies for medical applications, and foundational work done in part
by his team has led to the development and first in human testing of a
targeted nanoparticle capable of controlling drug release for treatment of cancers, and the first in human testing of a
targeted nanoparticle vaccine capable of orchestrating an immune response to facilitate smoking cessation and relapse prevention.
Collectively, our findings support
targeted disruption of constitutive TGF - β2 expression within the eye using antioxidant - encapsulating
nanoparticles and raises enthusiasm that this strategy will be a clinically useful and effective new therapy
by which to better manage IOP in patients with POAG.
RNA
nanoparticles must be within the range of 15 to 50 nanometers,» he says, «large enough to be retained
by the body and not enter cells randomly, causing toxicity, but small enough to enter the
targeted cells with the aid of cell surface receptions.
«To our knowledge, this is the first naked RNA
nanoparticles to have been comprehensively examined pharmacologically in vivo and demonstrated to be safe, as well as deliver itself to tumor tissues
by a specific
targeting mechanism,» he says.
Ultrasonic enhancement of photoacoustic emissions
by nanoparticle -
targeted cavitation.
Through the EPR effect,
nanoparticles larger than 8 nm (between 8 - 100 nm) can passively
target tumors
by freely pass through large pores and achieve higher intratumoral accumulation.»